The effect of Motilitone to Gastric Emptying time in patients with DIstal Gastrectomy

The effect of Motilitone to Gastric Emptying time in patients with DIstal Gastrectomy (MOGEDIG study)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0004084

Enrollment

Registered

2019-06-21

Start date

2018-04-18

Completion date

Unknown

Last updated

2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : To find out the Motilitone in patients who have undergone distal subtotal gastrectomy has an effect on representative gastroenterostomy Billroth I, Billroth II or Roux-en_Y, perform a gastric

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A patient who have undergone distal subtotal gastrectomy for one to three years ago (Billroth II, Roux an Y) 6month to three years ago (Billroth I)

Exclusion criteria

Exclusion criteria: Patient who relapse has been confirmed Visit emergency room for adhesive ileus Pastmedical history of hospital treatment for diabetic complication who take a gastrointestinal motility drug except digestant (the pation who is possible to skip the drug over 2 weeks can be included)

Design outcomes

Primary

Measure	Time frame
the change of radioactive half time on Gastric emptying study	—

Secondary

Measure	Time frame
Gastrointestinal symptome	—

Countries

Korea, Republic of

Contacts

Public ContactNayeong Gu

Chung-Ang Univerisity Hospital

na0282@naver.com+82-2-6299-1571

Outcome results